Abstract
Psoriasis is a chronic inflammatory disease that affects approximately 3.2% of the adult population of the USA. Amongst this population, Caucasians have the highest prevalence rate at 3.6%, while in non-Caucasians or individuals with skin of color the prevalence is lower, 1.9%, 1.6%, and 1.4% in African Americans, Hispanics, and other non-Caucasians, respectively [1]. Based on these statistics, one might gather that psoriasis is less likely in skin of color [2]. One of the earliest review articles detailing psoriasis prevalence by ethnic origin highlights several groups including the specific categories: Caucasian, African American, black-skinned South African, Fiji Islands, American Indian, Latin American Indian, Japanese, and Indonesians [3]. The 1965 text perpetuates the idea that psoriasis is relatively common in Caucasians and much less frequent in skin of color while acknowledging that psoriasis may not be as rare in those of African descent as previously believed. It was proposed that in evaluating the incidence of psoriasis among different ethnic groups, the potential influence of variables such as genetics, climate, diet, degree of skin pigmentation, exercise, stress level, economic factors, social factors, and hygiene factors must be considered [3]. This study was subject to selection bias as the text concluded that psoriasis was uncommon in black-skinned individuals during a time period when black-skinned individuals with psoriasis were much less likely to visit the dermatologist than white Caucasians.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rachakonda TD, Schupp CW, Armstrong AW. Psoriasis prevalence among adults in the United States. J Am Acad Dermatol. 2014;70:512–6.
Gelfand JM, Stern RS, Nijsten T, et al. The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol. 2005;52:23–6.
Farber EM, Grauer FZF. Racial incidence of psoriasis. Cesk Dermatol. 1965;40:289–97.
Porto Ferreira C, Martins CJ, Issa PR, et al. Psoriasis affects individuals of African descent and white Brazilians similarly. Actas Dermosifiliogr. 2010;101:230–4.
Leder RO, Farber EM. The variable incidence of psoriasis in sub-Saharan Africa. Int J Dermatol. 1997;36:911–9.
Parisi R, Symmons DPM, Griffiths CEM, et al. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2012;133:377–85.
Balato N, Di Costanzo L, Patruno C, et al. Effect of weather and environmental factors on the clinical course of psoriasis. Occup Environ Med. 2013;70:600.
Farber EM, Nall ML. The natural history of psoriasis in 5,600 patients. Dermatology. 1974;148:1–18.
Andersen LK, Davis MDP. The effects of the El Nino southern oscillation on skin and skin-related diseases: a message from the International Society of Dermatology Climate Change Task Force. Int J Dermatol. 2015;54:1343–51.
Barlow RJ, Schulz EJ. Chronic subcorneal pustulosis with vasculitis: a variant of generalized pustular psoriasis in black South Africans. Br J Dermatol. 1991;124:470–4.
Curtis AR, Yosipovitch G. Erythrodermic verrucous psoriasis. J Dermatolog Treat. 2012;23:215–8.
Delaney TA, Smith NP. Lichen planus mimicking and coexisting with psoriasis in a black patient. Australas J Dermatol. 1993;34:59–62.
McMichael AJ, Vachiramon V, Guzmán-Sánchez DA, Camacho F. Psoriasis in African-Americans: a caregivers’ survey. J Drugs Dermatol. 2012;11:478–82.
Petit A. Skin semiology and grading scales. In: Dadzie OE, Petit A, Alexis A, editors. Ethnic dermatology principles and practice. Chichester: Wiley-Blackwell; 2013. p. 5–17.
Bowcock AM, Krueger JG. Getting under the skin: the immunogenetics of psoriasis. Nat Rev Immunol. 2005;5:699–711.
Yao Y, Richman L, Morehouse C, et al. Type I interferon: potential therapeutic target for psoriasis? PLoS One. 2008;3:e2737.
Haider AS, Lowes M, Suà rez-Fariñas M, et al. Cellular genomic maps help dissect pathology in human skin disease. J Invest Dermatol. 2008;128:606–15.
Funk J, Langeland T, Schrumpf E, et al. Psoriasis induced by interferon-alpha. Br J Dermatol. 1991;125:463–5.
Büchau AS, Gallo RL. Innate immunity and antimicrobial defense systems in psoriasis. Clin Dermatol. 2007;25:616–24.
Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361:496–509.
Nickoloff BJ, Xin H, Nestle FO, et al. The cytokine and chemokine network in psoriasis. Clin Dermatol. 2007;25:568–73.
Indhumathi S, Rajappa M, Chandrashekar L, et al. TNFAIP3 and TNIP1 polymorphisms confer psoriasis risk in South Indian Tamils. Br J Biomed Sci. 2015;72:168–73.
Riveira-Munoz E, He S-M, EscaramÃs G, et al. Meta-analysis confirms the LCE3C_LCE3B deletion as a risk factor for psoriasis in several ethnic groups and finds interaction with HLA-Cw6. J Invest Dermatol. 2011;131:1105–9.
Gandhi G, Buttar BS, Albert L, et al. Psoriasis-associated genetic polymorphism in North Indian population in the CCHCR1 gene and in a genomic segment flanking the HLA-C region. Dis Markers. 2011;31:361–70.
Mrowietz U, Jessat H, Schwarz A, et al. Anthralin (dithranol) in vitro inhibits human monocytes to secrete IL-6, IL-8 and TNF-alpha, but not IL-1. Br J Dermatol. 1997;136:542–7.
Lowenthal KE, Horn PJ, Kalb RE. Concurrent use of methotrexate and acitretin revisited. J Dermatolog Treat. 2008;19:22–6.
van de Kerkhof PC, Cambazard F, Hutchinson PE, et al. The effect of addition of calcipotriol ointment (50 micrograms/g) to acitretin therapy in psoriasis. Br J Dermatol. 1998;138:84–9.
Fisher EJ, Adams BB. African American and Caucasian patients’ vehicle preference for the scalp. J Am Acad Dermatol. 2008;58(Suppl 1):1–6.
Farhangian ME, Anderson KL, Feldman S. Practical psoriasis management. Create Space Independent Publishing Platform; 2015.
Archier E, Devaux S, Castela E, et al. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol. 2012;26(Suppl 3):22–31.
Syed ZU, Hamzavi IH. Role of phototherapy in patients with skin of color. Semin Cutan Med Surg. 2011;30:184–9.
Youssef RM, Mahgoub D, Mashaly HM, et al. Different narrowband UVB dosage regimens in dark skinned psoriatics: a preliminary study. Photodermatol Photoimmunol Photomed. 2008;24:256–9.
Yeung H, Wan J, Van Voorhees AS, et al. Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis. J Am Acad Dermatol. 2013;68:64–72.
Rendon MI, Rodriguez DA, Kawata AK, et al. Acne treatment patterns, expectations, and satisfaction among adult females of different races/ethnicities. Clin Cosmet Investig Dermatol. 2015;8:231–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Cardwell, L.A., Kesty, C., Feldman, S.R., McMichael, A.J. (2018). Psoriasis in Skin of Color. In: Orfanos, C., Zouboulis, C., Assaf, C. (eds) Pigmented Ethnic Skin and Imported Dermatoses. Springer, Cham. https://doi.org/10.1007/978-3-319-69422-1_21
Download citation
DOI: https://doi.org/10.1007/978-3-319-69422-1_21
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-69421-4
Online ISBN: 978-3-319-69422-1
eBook Packages: MedicineMedicine (R0)